Transient/JJ
pseudo-hypoaldosteronism/NN
following/VBG
resection/NN
of/IN
the/DT
ileum/NN
:/:
normal/JJ
level/NN
of/IN
lymphocytic/JJ
aldosterone/NN
receptors/NNS
outside/IN
the/DT
acute/JJ
phase/NN
./.

Pseudo-hypoaldosteronism/NN
(/(
PHA/NN
)/)
is/VBZ
due/JJ
to/TO
mineralocorticoid/NN
resistance/NN
and/CC
manifests/VBZ
as/IN
hyponatremia/NN
and/CC
hyperkalemia/NN
with/IN
increased/VBN
plasma/NN
aldosterone/NN
levels/NNS
./.
=====
It/PRP
may/MD
be/VB
familial/JJ
or/CC
secondary/JJ
to/TO
abnormal/JJ
renal/JJ
sodium/NN
handling/NN
./.
=====
We/PRP
report/VBP
the/DT
case/NN
of/IN
a/DT
54-year-old/JJ
woman/NN
with/IN
multifocal/JJ
cancer/NN
of/IN
the/DT
colon/NN
,/,
who/WP
developed/VBD
PHA/NN
after/IN
subtotal/JJ
colectomy/NN
,/,
ileal/JJ
resection/NN
and/CC
jejunostomy/NN
./.
=====
She/PRP
was/VBD
treated/VBN
with/IN
6/CD
g/NN
of/IN
salt/NN
daily/RB
to/TO
prevent/VB
dehydration/NN
,/,
which/WDT
she/PRP
stopped/VBD
herself/PRP
because/IN
of/IN
reduced/VBN
fecal/JJ
losses/NNS
./.
=====
One/CD
month/NN
later/RB
she/PRP
was/VBD
admitted/VBN
with/IN
signs/NNS
of/IN
acute/JJ
adrenal/JJ
failure/NN
,/,
i.e./FW
fatigue/NN
,/,
severe/JJ
nausea/NN
,/,
blood/NN
pressure/NN
of/IN
80/60/CD
mmHg/NN
,/,
extracellular/JJ
dehydration/NN
,/,
hyponatremia/NN
(/(
118/CD
mmol/l/NN
)/)
;/:
hyperkalemia/NN
(/(
7.6/CD
mmol/l/NN
)/)
,/,
increased/VBN
blood/NN
urea/NN
nitrogen/NN
(/(
BUN/NN
)/)
(/(
200/CD
mg/dl/NN
)/)
and/CC
creatininemia/NN
(/(
2.5/CD
mg/dl/NN
)/)
,/,
and/CC
decreased/VBN
plasma/NN
bicarbonates/NNS
level/NN
(/(
HCO3-/JJ
:/:
16/CD
mmol/l/NN
;/:
N/NN
:/:
27-30/CD
)/)
./.
=====
However/RB
,/,
the/DT
plasma/NN
cortisol/NN
was/VBD
high/JJ
(/(
66/CD
microg/100/NN
ml/NN
at/IN
10:00/CD
h/NN
;/:
N/NN
:/:
8-15/CD
)/)
and/CC
the/DT
ACTH/NN
was/VBD
normal/JJ
(/(
13/CD
pg/ml/NN
,/,
N/NN
:/:
10-60/CD
)/)
;/:
there/EX
was/VBD
a/DT
marked/JJ
increase/NN
in/IN
plasma/NN
renin/NN
activity/NN
(/(
>/JJR
37/CD
ng/ml/h/NN
;/:
N/NN
supine/NN
</JJR
3/CD
)/)
,/,
active/JJ
renin/NN
(/(
869/CD
pg/ml/NN
;/:
N/NN
supine/NN
:/:
1.120/CD
)/)
,/,
aldosterone/NN
(/(
>/JJR
2000/CD
pg/ml/NN
;/:
N/NN
supine/NN
</JJR
150/CD
)/)
and/CC
plasma/NN
AVP/NN
(/(
20/CD
pmol/l/NN
;/:
N/NN
:/:
0.5-2.5/CD
)/)
./.
=====
The/DT
plasma/NN
ANH/NN
level/NN
was/VBD
38/CD
pmol/l/NN
(/(
N/NN
supine/NN
:/:
5-25/CD
)/)
./.
=====
A/DT
urinary/JJ
steroidogram/NN
resulted/VBD
in/IN
highly/RB
elevated/JJ
tetrahydrocortisol/NN
(/(
THF/NN
:/:
13.3/CD
mg/24h/NN
;/:
N/NN
:/:
1.4+/-0.8/CD
)/)
with/IN
no/DT
increase/NN
in/IN
tetrahydrocortisone/NN
(/(
THE/DT
:/:
3.16/CD
mg/24h/NN
;/:
N/NN
:/:
2.7+/-2.0/CD
)/)
excretion/NN
,/,
and/CC
with/IN
low/JJ
THE/THF/NN
(/(
0.24/CD
;/:
N/NN
:/:
1.87+/-0.36/CD
)/)
and/CC
alpha/NN
THF/THF/NN
(/(
0.35/CD
;/:
N/NN
:/:
0.92+/-0.42/CD
)/)
ratios/NNS
./.
=====
The/DT
number/NN
of/IN
mineralocorticoid/NN
receptors/NNS
in/IN
mononuclear/JJ
leukocytes/NNS
was/VBD
in/IN
the/DT
lower/JJR
normal/JJ
range/NN
for/IN
age/NN
,/,
while/IN
the/DT
number/NN
of/IN
glucocorticoid/NN
receptors/NNS
was/VBD
reduced/VBN
./.
=====
Small-bowel/JJ
resection/NN
in/IN
ileostomized/JJ
patients/NNS
causes/VBZ
excessive/JJ
fecal/JJ
sodium/NN
losses/NNS
and/CC
results/VBZ
in/IN
chronic/JJ
sodium/NN
depletion/NN
with/IN
contraction/NN
of/IN
the/DT
plasma/NN
volume/NN
and/CC
severe/JJ
secondary/JJ
hyperaldosteronism/NN
./.
=====
Nevertheless/RB
,/,
this/DT
hyperaldosteronism/NN
may/MD
be/VB
associated/VBN
with/IN
hyponatremia/NN
and/CC
hyperkalemia/NN
suggesting/VBG
PHA/NN
related/JJ
to/TO
the/DT
major/JJ
importance/NN
of/IN
the/DT
colon/NN
for/IN
the/DT
absorption/NN
of/IN
sodium/NN
./.
=====
In/IN
conclusion/NN
,/,
this/DT
case/NN
report/NN
emphasizes/VBZ
1/LS
)/)
the/DT
possibility/NN
of/IN
a/DT
syndrome/NN
of/IN
acquired/VBN
PHA/NN
with/IN
severe/JJ
hyperkalemia/NN
after/IN
resection/NN
of/IN
the/DT
ileum/NN
and/CC
colon/NN
responding/VBG
to/TO
oral/JJ
salt/NN
supplementation/NN
;/:
2/LS
)/)
the/DT
major/JJ
increase/NN
in/IN
AVP/NN
and/CC
the/DT
small/JJ
increase/NN
in/IN
ANH/NN
;/:
3/LS
)/)
the/DT
strong/JJ
increase/NN
in/IN
urinary/JJ
THF/NN
with/IN
low/JJ
THE/THF/NN
and/CC
alpha/NN
THF/THF/NN
ratios/NNS
;/:
4/LS
)/)
the/DT
normal/JJ
number/NN
of/IN
lymphocytic/JJ
mineralocorticoid/NN
receptors/NNS
outside/IN
the/DT
acute/JJ
episode/NN
./.